ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

ADVFN

Trade Now

EasyMarkets
Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P 500
4,567.18
(
-0.06%
)
US Tech 100
15,540.40
(
0.57%
)
Dow Jones
36,124.56
(
-0.22%
)
Brent Oil
77.315
(
0.35%
)
Bitcoin
44,015.83
(
-0.14%
)
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. SciSparc Ltd (SPRC)

  7. SciSparc Ltd (SPRC) News

SPRC SciSparc Ltd

7.23
-0.10 (-1.36%)
Dec 05 2023 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
SciSparc Ltd SPRC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
-0.10 -1.36% 7.23 19:56:05
Open Price Low Price High Price Close Price Prev Close
7.49 7.06 7.96 7.23 7.33
more quote information »

Recent News

Date Time Source Heading
12/01/202308:14GLOBEWeight Loss Treatment: SciSparc’s Obesity Drug Showed..
11/28/202316:55EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
11/28/202316:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/28/202316:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/28/202308:55GLOBESciSparc Adopts Limited Duration Shareholder Rights Plan
11/28/202308:25GLOBESciSparc Announces Positive Results from its Weight Loss and..
11/27/202316:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/27/202308:41GLOBESciSparc Announces Positive Results for MitoCareX Bio with..
11/24/202308:55GLOBENew Hope for Children: SciSparc's patented CBD- Enhanced..
11/24/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
11/22/202316:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/22/202307:42GLOBESciSparc Signs Non-Binding Letter of Intent to Merge with..
11/20/202316:22EDGAR2Form F-3/A - Registration statement by foreign private..
11/15/202308:01GLOBESciSparc Celebrates Major Breakthrough: Positive Results..
11/10/202309:10GLOBESciSparc Aims to Change Tourette Syndrome Treatments; Will..
11/03/202316:06EDGAR2Form F-3 - Registration statement by foreign private issuers
10/31/202308:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/31/202307:38GLOBESciSparc Granted Patent from the Australian Patent Office..
10/24/202307:54EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/24/202307:20GLOBESciSparc Granted Patent for its Core Technology From the..
10/18/202306:54EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/16/202317:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/16/202316:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/16/202308:17GLOBESciSparc Ltd. Regains Compliance with Nasdaq Minimum Bid..
10/13/202316:28GLOBESciSparc Ltd. Announces Closing of $5.026 Million Private..
10/12/202308:48EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/11/202309:15GLOBESciSparc Ltd. Announces Pricing of $5.026 Million Private..
10/03/202307:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/03/202307:33GLOBESciSparc Granted European Patent for its Core Technology
9/29/202307:46EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/29/202307:45GLOBESciSparc Initiated Its Clinical Trial with SCI-210 in..
9/27/202309:49IHNWSciSparc Announces Expected Implementation of 1-for-26..
9/27/202307:58GLOBESciSparc Announces Expected Implementation of 1-for-26..
9/21/202306:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/20/202306:30GLOBESciSparc Announces 1-for-26 Reverse Share Split
9/12/202309:15GLOBESciSparc Engages Investment Bank to Identify Potential..
9/07/202316:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/07/202309:15GLOBESciSparc Announces Initiation of Randomized Phase IIb..
9/07/202306:00GLOBESciSparc Granted 180-Day Extension by Nasdaq to Regain..
8/21/202317:14EDGAR2Form 144 - Report of proposed sale of securities
8/18/202316:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/14/202317:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/14/202316:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/14/202312:20GLOBESciSparc Ltd. Closes $1.3 Million Underwritten Public..
8/14/202309:14EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
8/10/202309:10GLOBESciSparc Ltd. Announces Pricing of $1.3 Million Underwritten..
8/10/202306:32EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/09/202316:40GLOBESciSparc Ltd. Announces Proposed Underwritten Public..
8/09/202316:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/01/202309:00GLOBEClearmind Medicine Files Patent Application with USPTO for..

Your Recent History

NASDAQ
SPRC
SciSparc
Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com